Advances in NSCLC
video
In NSCLC, Are Testing Panels Standardized?
While testing companies may differ, most physicians will run the same panels for their non-small cell lung cancer patients, explains Laurie Matt-Amaral, MD, of Cleveland Clinic. (1:39)
In NSCLC, Does Inflammation Predict Postsurgical Outcomes?
Measures of systemic inflammation have been developed as prognostic indexes, but few studies have examined the association between these indexes and NSCLC postsurgical outcomes. Researchers in the U.K. attempted to set the record straight.
NSCLC and Radiation Therapy: Can We Predict Acute Esophagitis?
Researchers in Michigan recently reported several predictors of esophagitis, a common adverse event during radiation therapy for locally advanced NSCLC. Some of these factors may seem familiar, others may not. Read on to learn the details.
The TNM-8 System for Lung Cancer Staging: An Overview
Among lung cancer care teams, an understanding of the TNM-8 clinical staging system is critical for prognosis and treatment selection. A newly published report lays out the key criteria, special considerations, and some potential future revisions.